{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:20:12Z","timestamp":1787728812046,"version":"build-2784847793"},"reference-count":85,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ejphar.2010.05.042","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T08:44:56Z","timestamp":1276159496000},"page":"75-81","source":"Crossref","is-referenced-by-count":59,"title":["Insulin-resistance and benign prostatic hyperplasia: The connection"],"prefix":"10.1016","volume":"641","author":[{"given":"Ajit","family":"Vikram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopabandhu","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poduri","family":"Ramarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.05.042_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1095\/biolreprod59.5.1163","article-title":"Age-dependent and lobe-specific spontaneous hyperplasia in the brown Norway rat prostate","volume":"59","author":"Banerjee","year":"1998","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejphar.2010.05.042_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3810\/psm.2009.12.1752","article-title":"Benign prostatic hyperplasia: does lifestyle play a role?","volume":"37","author":"Barnard","year":"2009","journal-title":"Phys. Sportsmed."},{"key":"10.1016\/j.ejphar.2010.05.042_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13813450902878054","article-title":"Obesity related hyperinsulinaemia and hyperglycaemia and cancer development","volume":"115","author":"Becker","year":"2009","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2010.05.042_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10911-008-9099-z","article-title":"IGF and insulin receptor signaling in breast cancer","volume":"13","author":"Belfiore","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.ejphar.2010.05.042_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000471742","article-title":"Pathogenesis of benign prostatic hyperplasia","volume":"20","author":"Bosch","year":"1991","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.urology.2006.01.007","article-title":"Macronutrients, fatty acids, cholesterol, and risk of benign prostatic hyperplasia","volume":"67","author":"Bravi","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2010.05.042_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.1112","article-title":"High fat diet increases the weight of rat ventral prostate","volume":"49","author":"Cai","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib9","first-page":"1284","article-title":"Pathological changes of benign hyperplastic prostate after removal of innervation of cholinergic pelvic nerve: experiment with spontaneous hypertension rats","volume":"88","author":"Cai","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ejphar.2010.05.042_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccm.2009.05.001","article-title":"The obesity epidemic","volume":"30","author":"Catenacci","year":"2009","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.ejphar.2010.05.042_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/pros.10096","article-title":"Insulin-like growth factors and risk of benign prostatic hyperplasia","volume":"52","author":"Chokkalingam","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.ph.55.030193.001023","article-title":"The insulin-like growth factors","volume":"55","author":"Cohick","year":"1993","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11886-001-0059-0","article-title":"Pathophysiology and treatment of the dyslipidemia of insulin resistance","volume":"3","author":"Cohn","year":"2001","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ejphar.2010.05.042_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0022-5347(05)64687-3","article-title":"Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia","volume":"168","author":"Dahle","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/pros.2990110403","article-title":"Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate","volume":"11","author":"de Voogt","year":"1987","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8","article-title":"Botox-induced prostatic involution","volume":"37","author":"Doggweiler","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-8529(05)70078-5","article-title":"Insulin-lowering therapeutic modalities for polycystic ovary syndrome","volume":"28","author":"Ehrmann","year":"1999","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2010.05.042_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0742-8413(96)00057-6","article-title":"Citral and testosterone interactions in inducing benign and atypical prostatic hyperplasia in rats","volume":"115","author":"Engelstein","year":"1996","journal-title":"Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/pros.20905","article-title":"Dietary fatty acid quality affects AR and PPARgamma levels and prostate growth","volume":"69","author":"Escobar","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib20","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1074\/jbc.M610447200","article-title":"Insulin-like growth factor 1\/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor","volume":"282","author":"Fan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.05.042_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00041433-199306000-00004","article-title":"Insulin resistance and lipid metabolism","volume":"4","author":"Frayn","year":"1993","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/oxfordjournals.aje.a117206","article-title":"Obesity and benign prostatic hyperplasia","volume":"140","author":"Giovannucci","year":"1994","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0045(19980215)34:3<214::AID-PROS9>3.0.CO;2-H","article-title":"Induction of atypical prostatic hyperplasia in rats by sympathomimetic stimulation","volume":"34","author":"Golomb","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.1939-4640.2000.tb03276.x","article-title":"Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats","volume":"21","author":"Golomb","year":"2000","journal-title":"J. Androl."},{"key":"10.1016\/j.ejphar.2010.05.042_bib25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.urology.2006.09.034","article-title":"Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans","volume":"68","author":"Gupta","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2010.05.042_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/080370599438365","article-title":"Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia","volume":"8","author":"Hammarsten","year":"1999","journal-title":"Blood Press."},{"key":"10.1016\/j.ejphar.2010.05.042_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000052430","article-title":"Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia","volume":"39","author":"Hammarsten","year":"2001","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","article-title":"Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia","volume":"1","author":"Hammarsten","year":"1998","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ejphar.2010.05.042_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/pcan.2008.50","article-title":"Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia","volume":"12","author":"Hammarsten","year":"2009","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ejphar.2010.05.042_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(05)67491-5","article-title":"Experimental diabetes-induced regression of the rat prostate is associated with an increased expression of transforming growth factor-beta","volume":"164","author":"Ikeda","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib31","first-page":"S4","article-title":"Medical therapy for benign prostatic hyperplasia\u2014present and future impact","volume":"13","author":"Issa","year":"2007","journal-title":"Am. J. Manage. Care"},{"key":"10.1016\/j.ejphar.2010.05.042_bib32","unstructured":"Karatas, O.F., Bayrak, O., Cimentepe, E., Unal, D., in press. An insidious risk factor for cardiovascular disease: Benign prostatic hyperplasia. Int. J. Cardiol. PMID: 19359054."},{"key":"10.1016\/j.ejphar.2010.05.042_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11934-996-0008-y","article-title":"Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"7","author":"Kasturi","year":"2006","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.ejphar.2010.05.042_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/biolreprod\/81.s1.563","article-title":"Evidence that insulin stimulates 5alpha-reductase (Type 1) mRNA and protein expression in ovarian granulosa cells: a possible mechanism of ovulatory dysfunction under hyperinsulinaemic state","volume":"81","author":"Kayampilly","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejphar.2010.05.042_bib35","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.042_bib36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s10517-009-0415-4","article-title":"Hormonal and biochemical parameters of metabolic syndrome in male patients with body weight excess and obesity","volume":"146","author":"Kogai","year":"2008","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2010.05.042_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.beem.2005.07.003","article-title":"Fatty acids and insulin resistance in muscle and liver","volume":"19","author":"Kovacs","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2010.05.042_bib38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.juro.2006.11.065","article-title":"Race\/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial","volume":"177","author":"Kristal","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/aja.2009.62","article-title":"Effects of obesity on lower urinary tract symptoms in Korean BPH patients","volume":"11","author":"Lee","year":"2009","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ejphar.2010.05.042_bib40","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1210\/en.2005-0505","article-title":"Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin\/IGF-I hybrid receptors in endothelial cells","volume":"146","author":"Li","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2010.05.042_bib41","first-page":"387","article-title":"Correlation of benign prostatic hyperplasia with hyperlipemia","volume":"43","author":"Li","year":"2005","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.ejphar.2010.05.042_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11934-008-0048-6","article-title":"Growth factors in benign prostatic hyperplasia: basic science implications","volume":"9","author":"Lucia","year":"2008","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.ejphar.2010.05.042_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0012-1606(02)00031-3","article-title":"Hormonal, cellular, and molecular control of prostatic development","volume":"253","author":"Marker","year":"2003","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/j.1939-4640.2003.tb02671.x","article-title":"Rapid proliferation of prostatic epithelial cells in spontaneously hypertensive rats: a model of spontaneous hypertension and prostate hyperplasia","volume":"24","author":"Matityahou","year":"2003","journal-title":"J. Androl."},{"key":"10.1016\/j.ejphar.2010.05.042_bib45","first-page":"1998","article-title":"Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture","volume":"44","author":"McKeehan","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2010.05.042_bib46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.ju.0000173072.73702.64","article-title":"Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"174","author":"McVary","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib47","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0895-4356(01)00351-1","article-title":"Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men","volume":"54","author":"Meigs","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib48","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1074\/jbc.M103728200","article-title":"Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells","volume":"277","author":"Montagnani","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.05.042_bib49","first-page":"57","article-title":"Prosaposin ablation inactivates the MAPK and Akt signaling pathways and interferes with the development of the prostate gland","volume":"5","author":"Morales","year":"2003","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ejphar.2010.05.042_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","article-title":"Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone","volume":"21","author":"Nam","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ejphar.2010.05.042_bib51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11255-008-9333-z","article-title":"Benign prostatic hyperplasia: dietary and metabolic risk factors","volume":"40","author":"Nandeesha","year":"2008","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cca.2006.01.019","article-title":"Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia","volume":"370","author":"Nandeesha","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2010.05.042_bib53","first-page":"203","article-title":"Effect of D-004, a lipid extract from Cuban royal palm fruit, on histological changes of prostate hyperplasia induced with testosterone in rats","volume":"27","author":"Noa","year":"2005","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.ejphar.2010.05.042_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","article-title":"The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia","volume":"51","author":"Ozden","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib55","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s11906-001-0065-z","article-title":"Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease","volume":"3","author":"Palatini","year":"2001","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejphar.2010.05.042_bib56","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urology.2008.03.043","article-title":"Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population","volume":"72","author":"Park","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2010.05.042_bib57","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2005-2799","article-title":"Metabolic factors associated with benign prostatic hyperplasia","volume":"91","author":"Parsons","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2010.05.042_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1464-410X.2007.07332.x","article-title":"Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men","volume":"101","author":"Parsons","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2010.05.042_bib59","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.juro.2009.07.086","article-title":"Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions","volume":"182","author":"Parsons","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib60","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00185974","article-title":"The insulin-like growth factor system in the prostate","volume":"13","author":"Peehl","year":"1995","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1464-410X.2007.07069.x","article-title":"An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat","volume":"100","author":"Rahman","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2010.05.042_bib62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.clnu.2004.02.006","article-title":"Dietary fat, insulin sensitivity and the metabolic syndrome","volume":"23","author":"Riccardi","year":"2004","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ejphar.2010.05.042_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-5347(17)32831-8","article-title":"Genetic susceptibility of benign prostatic hyperplasia","volume":"152","author":"Sanda","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11934-009-0044-5","article-title":"Diabetes and benign prostatic hyperplasia: emerging clinical connections","volume":"10","author":"Sarma","year":"2009","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.ejphar.2010.05.042_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000472615","article-title":"Early stages of the pathogenesis of rat ventral prostate hyperplasia induced by citral","volume":"12","author":"Servadio","year":"1986","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1097-0045(19980801)36:3<201::AID-PROS9>3.0.CO;2-J","article-title":"Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival","volume":"36","author":"Shabsigh","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2010.05.042_bib68","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2008.07.003","article-title":"Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat","volume":"56","author":"Silva","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jemt.1070300405","article-title":"Androgen, estrogen, and progesterone receptors in normal and aging prostates","volume":"30","author":"Srinivasan","year":"1995","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.ejphar.2010.05.042_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/818965","article-title":"The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review","author":"Stamatiou","year":"2009","journal-title":"Adv. Urol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-2999(02)02452-4","article-title":"Enhancement of alpha-adrenoceptor-mediated responses in prostate of testosterone-treated rat","volume":"453","author":"Thiyagarajan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib73","first-page":"79","article-title":"The autonomic nervous system function in benign prostatic hyperplasia","volume":"47","author":"Thor","year":"2006","journal-title":"Folia Med. Cracov."},{"key":"10.1016\/j.ejphar.2010.05.042_bib74","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/j.1460-2075.1986.tb04528.x","article-title":"Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity","volume":"5","author":"Ullrich","year":"1986","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2010.05.042_bib75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.taap.2007.09.006","article-title":"Intervention of d-glucose ameliorates the toxicity of streptozotocin in accessory sex organs of rat","volume":"226","author":"Vikram","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/pros.21041","article-title":"Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia","volume":"70","author":"Vikram","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2010.05.042_bib77","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.clinbiochem.2009.06.011","article-title":"BMI and hyperinsulinemia in children","volume":"42","author":"Vogeser","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2010.05.042_bib78","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1210\/en.2003-1716","article-title":"Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase\/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells","volume":"145","author":"Wadsworth","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2010.05.042_bib79","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00004872-199603000-00005","article-title":"Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study","volume":"14","author":"Ward","year":"1996","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2010.05.042_bib80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.abb.2004.04.023","article-title":"Lycopene: modes of action to promote prostate health","volume":"430","author":"Wertz","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2010.05.042_bib81","first-page":"830","article-title":"Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension","volume":"13","author":"Yang","year":"2007","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.ejphar.2010.05.042_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00210-005-0010-9","article-title":"Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes","volume":"372","author":"Yono","year":"2005","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.05.042_bib83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.lfs.2008.06.006","article-title":"Differential effects of diabetes induced by streptozotocin and that develops spontaneously on prostate growth in Bio Breeding (BB) rats","volume":"83","author":"Yono","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.05.042_bib84","doi-asserted-by":"crossref","first-page":"50230","DOI":"10.1074\/jbc.M200958200","article-title":"Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.05.042_bib85","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/sj.ijo.0802979","article-title":"History of weight and obesity through life and risk of benign prostatic hyperplasia","volume":"29","author":"Zucchetto","year":"2005","journal-title":"Int. J. Obes."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910004929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910004929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:18:18Z","timestamp":1711549098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910004929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":85,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0014299910004929"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.05.042","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}